Page last updated: 2024-10-29

ketanserin and Anorexia

ketanserin has been researched along with Anorexia in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grignaschi, G1
Mantelli, B1
Samanin, R1
Hewson, G1
Leighton, GE1
Hill, RG1
Hughes, J1

Other Studies

2 other studies available for ketanserin and Anorexia

ArticleYear
The hypophagic effect of restraint stress in rats can be mediated by 5-HT2 receptors in the paraventricular nucleus of the hypothalamus.
    Neuroscience letters, 1993, Apr-02, Volume: 152, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amidines; Animals; Anorexia; Anorexia Nervosa; Disease Model

1993
Ketanserin antagonises the anorectic effect of DL-fenfluramine in the rat.
    European journal of pharmacology, 1988, Jan-12, Volume: 145, Issue:2

    Topics: Animals; Anorexia; Fenfluramine; Ketanserin; Male; Prazosin; Rats; Receptors, Adrenergic; Receptors,

1988